News - Biotechnology
Aussie biotechs sweep top honours in Asia Pacific cell and gene therapy
Two Australian biotechnology companies have taken centre stage at the Asia Pacific Cell & Gene Therapy Excellence Awards 2025 (APCGTEA […]
MoreNews - Biotechnology
CSL restructures amid R&D setbacks and vaccines uncertainty
CSL, Australia’s largest biotech company, is embarking on its most radical shake-up in years, slashing 15% of its workforce – […]
MoreNews - Biotechnology
ASX biotech Alterity edges closer to first treatment for rare neurodegenerative disease
An ASX-listed biotech is pushing the boundaries of neurodegenerative research with the development of an AI-powered neuroimaging tool designed to […]
MoreNews - Biotechnology
Australia’s IP trends reveal post-pandemic innovation shift
Australia’s life sciences sector continues to evolve amidst a dynamic landscape of intellectual property (IP) rights, particularly patents, which are […]
MoreNews - Biotechnology
CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
MoreNews - Biotechnology
National push to tackle cardiovascular and diabetes burden backs Aussie start-ups
Fourteen biotech and medtech innovators will share in a $12 million funding injection aimed at fast-tracking life-changing solutions for people […]
MoreNews - Biotechnology
Aussie-invented smart capsule wins regulatory nod
An ingestible gas-sensing capsule originally developed at RMIT University has received regulatory clearance from the U.S. Food and Drug Administration […]
MoreNews - Biotechnology
QBiotics reports promising data in rare cancer trial
On Rare Cancers Awareness Day (26 June), Australian biotech QBiotics Group unveiled the final efficacy and safety results from stage […]
MoreNews - Biotechnology
AusBiotech champions Australia’s momentum in the global life sciences race
AusBiotech has wrapped up a week packed with bilateral and multilateral engagements at the BIO International Convention 2025 in Boston. […]
MoreNews - Biotechnology
Local biotech earns green light to manufacture next-gen cell therapies
A Melbourne-based biotech company has secured a stem cell manufacturing licence from the Therapeutic Goods Administration (TGA), a move that […]
MoreRecent Posts in Pharma, MedTech & Biotech
Decoding Alzheimer’s at the crossroads of science and policy
September 24, 2025
in News - MedTech & Diagnostics
Secrecy and monopoly concerns shadow Moderna’s mRNA facility
September 24, 2025
in News - Biotechnology
Clinicians map role of MSD drug in pulmonary arterial hypertension post PBAC rejection
September 24, 2025
in News - Pharmaceuticals
Healthcare system failing young Aussies: Three in four forced to change care due to cost
September 24, 2025
in News - MedTech & Diagnostics
Patients say ‘no more reviews or rhetoric’ as HTA reform crawls
September 22, 2025
in News - Pharmaceuticals
Four pharma leaders vie for two Medicines Australia Board seats
September 22, 2025
in News - Pharmaceuticals
Charting a shared path: Patients, clinicians and industry unite for aggressive lymphoma
September 22, 2025
in News - Pharmaceuticals
Colonoscopy access: Postcode and pay packet still dictate outcomes
September 22, 2025
in News - MedTech & Diagnostics
Follow Us
Partner with us
News - MedTech & Diagnostics
Decoding Alzheimer’s at the crossroads of science and policy
This World Alzheimer’s Day, Anand Vairavan, Managing Director of Roche Diagnostics Australia, and Professor Matthew Kiernan, CEO of NeuRA and […]
MoreNews - Biotechnology
Secrecy and monopoly concerns shadow Moderna’s mRNA facility
Australia’s first large-scale mRNA manufacturing facility promises significant economic and health dividends, but critics warn it gives one global company […]
MoreNews - Pharmaceuticals
Clinicians map role of MSD drug in pulmonary arterial hypertension post PBAC rejection
The Department of Health has released the outcomes from its pulmonary arterial hypertension (PAH) stakeholder meeting held in August. This […]
MoreNews - MedTech & Diagnostics
Healthcare system failing young Aussies: Three in four forced to change care due to cost
Three in four Australians (76%) are now changing their healthcare decisions due to financial pressures, with young adults and women […]
More